KDR and neoplasm: Immunohistochemistry results show that SH003 reduced the expression of Ki-67, phospho-VEGFR2 and vascular endothelial cell marker (CD31), and increased apoptosis marker (cleaved caspase 3) in tumor tissues, suggesting that SH003 administration decreased the tumor growth by inhibiting tumor angiogenesis.